210 related articles for article (PubMed ID: 32642565)
1. On-line adaptive MR guided radiotherapy for locally advanced pancreatic cancer: Clinical and dosimetric considerations.
Placidi L; Romano A; Chiloiro G; Cusumano D; Boldrini L; Cellini F; Mattiucci GC; Valentini V
Tech Innov Patient Support Radiat Oncol; 2020 Sep; 15():15-21. PubMed ID: 32642565
[TBL] [Abstract][Full Text] [Related]
2. Combined Inter- and Intrafractional Plan Adaptation Using Fraction Partitioning in Magnetic Resonance-guided Radiotherapy Delivery.
Lagerwaard F; Bohoudi O; Tetar S; Admiraal MA; Rosario TS; Bruynzeel A
Cureus; 2018 Apr; 10(4):e2434. PubMed ID: 29876156
[TBL] [Abstract][Full Text] [Related]
3. Identification of patients with locally advanced pancreatic cancer benefitting from plan adaptation in MR-guided radiation therapy.
Bohoudi O; Bruynzeel AME; Meijerink MR; Senan S; Slotman BJ; Palacios MA; Lagerwaard FJ
Radiother Oncol; 2019 Mar; 132():16-22. PubMed ID: 30825964
[TBL] [Abstract][Full Text] [Related]
4. Role of Daily Plan Adaptation in MR-Guided Stereotactic Ablative Radiation Therapy for Adrenal Metastases.
Palacios MA; Bohoudi O; Bruynzeel AME; van Sörsen de Koste JR; Cobussen P; Slotman BJ; Lagerwaard FJ; Senan S
Int J Radiat Oncol Biol Phys; 2018 Oct; 102(2):426-433. PubMed ID: 29902559
[TBL] [Abstract][Full Text] [Related]
5. Fast and robust online adaptive planning in stereotactic MR-guided adaptive radiation therapy (SMART) for pancreatic cancer.
Bohoudi O; Bruynzeel AME; Senan S; Cuijpers JP; Slotman BJ; Lagerwaard FJ; Palacios MA
Radiother Oncol; 2017 Dec; 125(3):439-444. PubMed ID: 28811038
[TBL] [Abstract][Full Text] [Related]
6. Optimization of treatment planning workflow and tumor coverage during daily adaptive magnetic resonance image guided radiation therapy (MR-IGRT) of pancreatic cancer.
Olberg S; Green O; Cai B; Yang D; Rodriguez V; Zhang H; Kim JS; Parikh PJ; Mutic S; Park JC
Radiat Oncol; 2018 Mar; 13(1):51. PubMed ID: 29573744
[TBL] [Abstract][Full Text] [Related]
7. Feasibility of Adaptive MR-guided Stereotactic Body Radiotherapy (SBRT) of Lung Tumors.
Padgett KR; Simpson GN; Llorente R; Samuels MA; Dogan N
Cureus; 2018 Apr; 10(4):e2423. PubMed ID: 29872603
[TBL] [Abstract][Full Text] [Related]
8. Benefit of replanning in MR-guided online adaptive radiation therapy in the treatment of liver metastasis.
Mayinger M; Ludwig R; Christ SM; Dal Bello R; Ryu A; Weitkamp N; Pavic M; Garcia Schüler H; Wilke L; Guckenberger M; Unkelbach J; Tanadini-Lang S; Andratschke N
Radiat Oncol; 2021 May; 16(1):84. PubMed ID: 33947429
[TBL] [Abstract][Full Text] [Related]
9. Dosimetric Benefits and Practical Pitfalls of Daily Online Adaptive MRI-Guided Stereotactic Radiation Therapy for Pancreatic Cancer.
El-Bared N; Portelance L; Spieler BO; Kwon D; Padgett KR; Brown KM; Mellon EA
Pract Radiat Oncol; 2019 Jan; 9(1):e46-e54. PubMed ID: 30149192
[TBL] [Abstract][Full Text] [Related]
10. In Silico Trial of MR-Guided Midtreatment Adaptive Planning for Hypofractionated Stereotactic Radiation Therapy in Centrally Located Thoracic Tumors.
Henke LE; Kashani R; Hilliard J; DeWees TA; Curcuru A; Przybysz D; Green O; Robinson CG; Bradley JD
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):987-995. PubMed ID: 29953910
[TBL] [Abstract][Full Text] [Related]
11. Assessment of online adaptive MR-guided stereotactic body radiotherapy of liver cancers.
Padgett KR; Simpson G; Asher D; Portelance L; Bossart E; Dogan N
Phys Med; 2020 Sep; 77():54-63. PubMed ID: 32781388
[TBL] [Abstract][Full Text] [Related]
12. Case Report: First in Human Online Adaptive MR Guided SBRT of Peritoneal Carcinomatosis Nodules: A New Therapeutic Approach for the Oligo-Metastatic Patient.
Boldrini L; Romano A; Placidi L; Mattiucci GC; Chiloiro G; Cusumano D; Pollutri V; Antonelli MV; Indovina L; Gambacorta MA; Valentini V
Front Oncol; 2020; 10():601739. PubMed ID: 33384958
[TBL] [Abstract][Full Text] [Related]
13. Dosimetric benefit of MR-guided online adaptive radiotherapy in different tumor entities: liver, lung, abdominal lymph nodes, pancreas and prostate.
Nierer L; Eze C; da Silva Mendes V; Braun J; Thum P; von Bestenbostel R; Kurz C; Landry G; Reiner M; Niyazi M; Belka C; Corradini S
Radiat Oncol; 2022 Mar; 17(1):53. PubMed ID: 35279185
[TBL] [Abstract][Full Text] [Related]
14. Retrospective study comparing MR-guided radiation therapy (MRgRT) setup strategies for prostate treatment: repositioning vs. replanning.
Kim JI; Park JM; Choi CH; An HJ; Kim YJ; Kim JH
Radiat Oncol; 2019 Aug; 14(1):139. PubMed ID: 31387593
[TBL] [Abstract][Full Text] [Related]
15. Clinical implementation of magnetic resonance imaging guided adaptive radiotherapy for localized prostate cancer.
Tetar SU; Bruynzeel AME; Lagerwaard FJ; Slotman BJ; Bohoudi O; Palacios MA
Phys Imaging Radiat Oncol; 2019 Jan; 9():69-76. PubMed ID: 33458428
[TBL] [Abstract][Full Text] [Related]
16. Impact of intrafraction motion in pancreatic cancer treatments with MR-guided adaptive radiation therapy.
Rusu DN; Cunningham JM; Arch JV; Chetty IJ; Parikh PJ; Dolan JL
Front Oncol; 2023; 13():1298099. PubMed ID: 38162503
[TBL] [Abstract][Full Text] [Related]
17. Dosimetric Quality of Online Adapted Pancreatic Cancer Treatment Plans on an MRI-Guided Radiation Therapy System.
Chow PE; Chu FI; Agazaryan N; Cao M; Tyran M; Yang Y; Low D; Raldow A; Lee P; Steinberg M; Lamb JM
Adv Radiat Oncol; 2021; 6(3):100682. PubMed ID: 33898868
[TBL] [Abstract][Full Text] [Related]
18. Dosimetric evaluation of magnetic resonance imaging-guided adaptive radiation therapy in pancreatic cancer by extent of re-contouring of organs-at-risk.
Song JY; Chie EK; Kang SH; Jeon YJ; Ko YA; Kim DY; Kang HC
Radiat Oncol J; 2022 Dec; 40(4):242-250. PubMed ID: 36606301
[TBL] [Abstract][Full Text] [Related]
19. Retrospective evaluation of decision-making for pancreatic stereotactic MR-guided adaptive radiotherapy.
Tyran M; Jiang N; Cao M; Raldow A; Lamb JM; Low D; Luterstein E; Steinberg ML; Lee P
Radiother Oncol; 2018 Nov; 129(2):319-325. PubMed ID: 30174107
[TBL] [Abstract][Full Text] [Related]
20. Stereotactic MR-Guided Online Adaptive Radiation Therapy (SMART) for Ultracentral Thorax Malignancies: Results of a Phase 1 Trial.
Henke LE; Olsen JR; Contreras JA; Curcuru A; DeWees TA; Green OL; Michalski J; Mutic S; Roach MC; Bradley JD; Parikh PJ; Kashani R; Robinson CG
Adv Radiat Oncol; 2019; 4(1):201-209. PubMed ID: 30706029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
